InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Coleman Blaise, 首席执行官. Director active across 1 company, notably Endo International plc. Cumulatively, 2 disclosures have been logged. History available since 5 March 2022. The latest transaction was disclosed on 29 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Blaise Coleman is the President and CEO of Endo International plc. He oversees the company's overall strategy and operations. With expertise in the pharmaceutical sector, he is committed to leading innovation and developing treatments that meet patient needs. His leadership is crucial for Endo's success.